How to study and overcome tumor heterogeneity with circulating biomarkers: The breast cancer case
Author:
Funder
AIRC
Publisher
Elsevier BV
Subject
Cancer Research
Reference105 articles.
1. Follow-up strategies for women treated for early breast cancer;Moschetti;Cochrane Database Syst. Rev.,2016
2. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?;Pagani;J. Natl. Cancer Inst.,2010
3. Liquid biopsy: potential and challenges;Pantel;Mol. Oncol.,2016
4. Breast tumor heterogeneity: source of fitness, hurdle for therapy;Koren;Mol. Cell,2015
5. Clinical management of breast cancer heterogeneity;Zardavas;Nat. Rev. Clin. Oncol.,2015
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi‐omic analysis;PROTEOMICS;2024-01-03
2. Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients;International Journal of Molecular Sciences;2023-12-02
3. Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer;Frontiers in Genetics;2023-03-16
4. Tumor-Promoting Properties of TMEM9A in Breast Cancer Progression <i>via</i> Activating the Wnt/β-Catenin Signaling Pathway;Biological and Pharmaceutical Bulletin;2023-01-01
5. A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer;Frontiers in Oncology;2022-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3